Zurisaday Sheccid Muñoz

Dr. Zurisaday Sheccid Muñoz


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 October 2025 in Microorganisms
Verified
Journal Article
Open access
PDF file
LRLuis Mario Rodríguez-Martínez
Luis Mario Rodríguez-Martínez
JCJose Luis Chavelas-Reyes
Jose Luis Chavelas-Reyes
CRCarlo Franco Medina Ramirez
Carlo Franco Medina Ramirez
ECEli de Jesús Fuentes Chávez
Eli de Jesús Fuentes Chávez
ZMZurisaday Sheccid Muñoz
Zurisaday Sheccid Muñoz
JRJosefina G. Rodríguez-González
Josefina G. Rodríguez-González
Tuberculosis (TB), caused by Mycobacterium tuberculosis, continues to be a leading cause of morbidity and mortality in Mexico, with more than 20,000 new cases annually and a rising proportion of drug-resistant strains. This work addresses the molecular epidemiology of TB in the Mexican context, emphasizing its role in understanding transmission, genetic diversity, and resistance mechanisms. To achieve this, we reviewed molecular typing approaches including spoligotyping, Mycobacterial Interspersed Repetitive Unit–Variable Number Tandem Repeat (MIRU-VNTR) analysis, and whole-genome sequencing (WGS), which have been applied to characterize circulating lineages and identify drug-resistance-associated mutations. The results indicate that the Euro-American lineage (L4) predominates across the country, although significant regional variation exists, with Haarlem, LAM, T, and X sub lineages dominating in different states, and occasional detection of Asian (L2) and Indo-Oceanic (L1) lineages. Key resistance mutations were identified in katG, rpoB, pncA, and gyrA, contributing to the emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains, particularly in border and marginalized regions. These findings highlight how social factors, such as migration, urban overcrowding, and comorbidities including diabetes and HIV, influence transmission dynamics. We conclude that integrating molecular tools with epidemiological surveillance is crucial for strengthening public health strategies and guiding interventions tailored to Mexico’s heterogeneous TB burden.